Zanacea Biotec Private Limited
About Zanacea Biotec Private Limited
Data last updated:
Zanacea Biotec Private Limited is a private limited company based in Sikar, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 April 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1999PTC015559. Its GSTIN is 08AAACZ1417B1ZS (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Vinod Kumar Sharma and Sampat Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Krishan Bhawan Behind Maru Mandir Near Ravindra Bal Niketan, Sikar, Rajasthan, India – 332001.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.37 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹29.09 Lakh (net margin 1.8%) and EBITDA of ₹55.12 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹53 Lakh and satisfied charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zanacea Biotec Private Limited's registered office is in Sikar, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKrishan Bhawan Behind Maru Mandir Near Ravindra Bal Niketan, Sikar, Rajasthan, India – 332001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zanacea Biotec Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zanacea Biotec is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zanacea Biotec Private Limited, buy the company report.
Financials of Zanacea Biotec Private Limited
FY 2025 filings availableZanacea Biotec Private Limited reported revenue of ₹16.37 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 4% growth in the latest year. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zanacea Biotec Private Limited, buy the company report.
Board of directors of Zanacea Biotec Private Limited
Zanacea Biotec has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Kumar Sharma | Director | 23 Apr 1999 | 27 Years 6 Months | Current |
| Sampat Sharma | Director | 14 Jun 2007 | 19 Years 4 Months | Current |
Peer comparison
Zanacea Biotec Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xena Coronus Health Care Private Limited | ₹16.54 Cr (FY 2025) | 30.0% | Indore, Madhya Pradesh, India | |||
| Metpharm Biotech Private Limited | ₹16.53 Cr (FY 2024) | -68.0% | Navsari, Gujarat, India | |||
| Zanacea Biotec Private Limitedthis company | ₹16.37 Cr (FY 2025) | ₹29.09 Lakh | 1.8% | 4.0% | Sikar, Rajasthan, India | |
| Vignaharta Enterprises Private Limited | ₹16.36 Cr (FY 2025) | 52.0% | Mohali, Punjab, India | |||
| Raishahib Gangaram Chowdhury & Sons Co Pvt Ltd | ₹16.35 Cr (FY 2025) | 25.0% | Assam, India | |||
| 3S Pharmaceuticals India Private Limited | ₹16.32 Cr (FY 2024) | -11.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Zanacea Biotec Private Limited, buy the company report.
Auditor
Zanacea Biotec Private Limited is audited by JAIN SAWAIMAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN SAWAIMAL & CO | FY 2019 | 000847C |
Shareholding
The shareholding of Zanacea Biotec Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Zanacea Biotec Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2016 | 100057004 | United Bank of India | ₹53 Lakh | Open | |
| 28 Feb 2013 | 10421903 | Axis Bank Ltd. | ₹50 Lakh | Satisfied |
To see the full charge records of Zanacea Biotec Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Zanacea Biotec Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zanacea Biotec Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zanacea Biotec has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACZ1417B1ZS | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zanacea Biotec Private Limited, buy the company report.
Recent activity
Zanacea Biotec Private Limited has 2 board changes on record since 1999: 2 appointments. The latest: Sampat Sharma was appointed as Director on 14 Jun 2007.
Frequently asked questions
Zanacea Biotec is an active private limited company based in Sikar, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 April 1999 (27+ years old) and is registered under CIN U24232RJ1999PTC015559.
Zanacea Biotec has 2 current directors:
- Vinod Kumar Sharma - Director
- Sampat Sharma - Director
The latest financial statements of Zanacea Biotec on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zanacea Biotec is 08AAACZ1417B1ZS, registered in Rajasthan.
The CIN (Corporate Identification Number) of Zanacea Biotec is U24232RJ1999PTC015559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zanacea Biotec was incorporated on 23 April 1999, making it 27+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Zanacea Biotec by revenue are Xena Coronus Health Care Private Limited, Metpharm Biotech Private Limited, Vignaharta Enterprises Private Limited, Raishahib Gangaram Chowdhury & Sons Co Pvt Ltd, 3S Pharmaceuticals India Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sampat Sharma was appointed as Director on 14 Jun 2007. Vinod Kumar Sharma was appointed as Director on 23 Apr 1999.
The registered office of Zanacea Biotec is at Krishan Bhawan Behind Maru Mandir Near Ravindra Bal Niketan, Sikar, Rajasthan, India – 332001.
Zanacea Biotec operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Zanacea Biotec has open charges of ₹53 Lakh and satisfied charges of ₹50 Lakh as per latest MCA filings.